DRISCOLL JOSEPH 4
4 · Akoya Biosciences, Inc. · Filed Dec 27, 2022
Insider Transaction Report
Form 4
DRISCOLL JOSEPH
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-22$0.44/sh+250,000$110,000→ 262,500 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-12-22−250,000→ 110,958 totalExercise: $0.44Exp: 2029-05-02→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The option will be fully vested on 03/18/2023.